Prevention of migraine in women throughout the life span

Mayo Clinic Proceedings

Volumn 81, Issue 8, 2006, Pages 1086-1092

  Tozer, Beverly S ^a   Boatwright, Elizabeth A ^a   David, Paru S ^a   Verma, Deepa P ^a   Blair, Janis E ^a   Mayer, Anita P ^a   Files, Julia A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CAFERGOT; CALCIUM CHANNEL BLOCKING AGENT; CYPROHEPTADINE; DOXEPIN; FLUOXETINE; FROVATRIPTAN; GABAPENTIN; LISINOPRIL; MAGNESIUM; METOPROLOL TARTRATE; NADOLOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PAROXETINE; PROPRANOLOL; PROTRIPTYLINE; RIBOFLAVIN; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TIMOLOL MALEATE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROATE SEMISODIUM; VERAPAMIL;

ABDOMINAL PAIN; ANTICHOLINERGIC EFFECT; CONSTIPATION; DIARRHEA; ECONOMIC ASPECT; FATIGUE; FEMALE; HUMAN; INCREASED APPETITE; INSOMNIA; LIFESPAN; MIGRAINE; NAUSEA; NEURAL TUBE DEFECT; OVARY POLYCYSTIC DISEASE; PANCREATITIS; PREVALENCE; REBOUND; SEDATION; SEIZURE; SHORT SURVEY; SIDE EFFECT; SKIN TINGLING; SOCIAL ASPECT; TREATMENT INDICATION; TREMOR; WEIGHT GAIN;

EID: 33746782898     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/81.8.1086     Document Type: Review

References (26)

1. Landy S. Migraine throughout the life cycle: treatment through the ages. Neurology. 2004;62 Suppl 2:S2-8.
2. Gladstone JP, Eross EJ, Dodick DW. Migraine in special populations: treatment strategies for children and adolescents, pregnant women, and the elderly. Postgrad Med. 2004;115:39-44, 47-50.
3. Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM, US Headache Consortium. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. Available at: http://www.aan.com/professionals/practice/guideline/index.cfm? fuseaction=home.view&guideline=71. Accessed May 24, 2006.
4. Silberstein SD, Saper JR, Freitag FG. Migraine: diagnosis and treatment. In: Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff's Headache and Other Head Pain. 7th ed. Oxford: Oxford University Press; 2001:121-237.
5. Martin VT, Behbehani MM. Toward a rational understanding of migraine trigger factors. Med Clin North Am. 2001;85:911-941.
6. Bigal ME, Krymchantowski AV, Rapoport AM. Prophylactic migraine therapy: emerging treatment options. Curr Pain Headache Rep. 2004;8:178-184.
7. Linder SL, Winner P. Pediatric headache. Med Clin North Am. 2001;85:1037-1053.
8. Lewis DW. Headaches in children and adolescents. Am Fam Physician. 2002;65:625-632.
9. Physicians' Desk Reference 2005. 59th ed. Montvale, NJ: Thomson PDR; 2004.
10. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63:2215-2224. Updated on June 28, 2006, from www.neurology.org/cgi/content/full/63/12/2215.
11. Wasiewski WW. Preventive therapy in pediatric migraine. J Child Neurol. 2001;16:71-78.
12. Pringsheim T, Edmeads J. Effective treatment of migraine: terminating acute attacks, reducing their frequency. Postgrad Med. 2004;115:28-30, 33-34, 38 passim.
13. Calhoun AH. A novel specific prophylaxis for menstrual-associated migraine. South Med J. 2004;97:819-822.
14. Silberstein SD. Headache and female hormones: what you need to know. Curr Opin Neurol. 2001;14:323-333.
15. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd ed, Cephalalgia. 2004;24(suppl 1):9-160.
16. Massiou H, MacGregor EA. Evolution and treatment of migraine with oral contraceptives. Cephalalgia. 2000;20:170-174.
17. Allais G, Bussone D, De Lorenzo C, Mana O, Benedetto C. Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects. Neurol Sci. 2005;26(suppl 2):s125-s129.
18. Silberstein SD, Elkind AH, Schreiber C, Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology. 2004;63:261-269.
19. Silberstein SD. Sex hormones and headache. Rev Neurol (Paris). 2000;156(suppl 4):4S30-4S41.
20. Mannix LK. Management of menstrual migraine. Neurologist. 2003;9:207-213.
21. Bousser MG, Conard J, Kittner S, et al, The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Recommendations on the risk of ischemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. Cephalalgia. 2000;20:155-156.
22. Tietjen GE. The risk of stroke in patients with migraine and implications for migraine treatment. CNS Drugs. 2005;19:683-692.
23. Johnson CJ. Headache in women. Prim Care. 2004;31:417-428.
24. Marcus DA. Pregnancy and chronic headache. Expert Opin Pharmacother. 2002;3:389-393.
25. North American Menopause Society. Menopause Core Curriculum Study Guide. Cleveland, Ohio: North American Menopause Society; 2000:13-29.
26. Silberstein SD, Winner PK, Chmiel JJ. Migraine preventive medication reduces resource utilization. Headache. 2003;43:171-178.